Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of GSK961081 and Fluticasone Furoate in Healthy Volunteers
NCT02064504Phase 1Completed
- Sponsor
- GSK
- Start
- Feb 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of batefenterol in chronic obstructive pulmonary disease (COPD) (6 arms), sponsored by GSK. Primary endpoint: GSK961081 Area Under the Curve from time zero to last time point. Started Feb 2014; status: completed.
02
Drugs
batefenterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02064504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02064504.